Van der Horst Edward's most recent trade in Sensei Biotherapeutics Inc was a trade of 2,276 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics Inc | Edward Van der Horst | CHIEF SCIENTIFIC OFFICER | 19 Feb 2025 | 2,276 | 59,794 | - | 0.5 | 1,083 | Common Stock | |
| Sensei Biotherapeutics Inc | Edward Van der Horst | CHIEF SCIENTIFIC OFFICER | 14 Feb 2025 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | Van der Horst Edward | CHIEF SCIENTIFIC OFFICER | 20 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | Van der Horst Edward | CHIEF SCIENTIFIC OFFICER | 15 Feb 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | Edward Van der Horst | CHIEF SCIENTIFIC OFFICER | 15 Feb 2024 | 90,102 | 90,102 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | Edward Van der Horst | CHIEF SCIENTIFIC OFFICER | 15 Feb 2024 | 2,843 | 56,070 | - | 0.8 | 2,246 | Common Stock | |
| Sensei Biotherapeutics Inc | Edward Van der Horst | Chief Scientific Officer | 15 Feb 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | Edward Van der Horst | Chief Scientific Officer | 15 Feb 2023 | 23,565 | 44,738 | - | 0 | Common Stock | ||
| Sensei Biotherapeutics Inc | Edward Van der Horst | Chief Scientific Officer | 15 Feb 2023 | 17,700 | 62,438 | - | 0 | Common Stock |